|
BAC
|
Financial Services |
CitigroupC |
Upgrade
|
Neutral
→
Buy
|
—
|
$386.6B
|
$44.77
|
+0.8%
|
+0.8%
|
+2.1%
|
-0.5%
|
+0.0%
|
+0.1%
|
|
HD
|
Consumer Cyclical |
Telsey Advisory GroupD |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$301.5B
|
$399.44
|
+1.1%
|
+1.6%
|
+0.6%
|
-1.3%
|
+1.8%
|
-1.1%
|
|
ANET
|
Technology |
Rosenblatt |
Maintains
|
Sell
→
Sell
|
—
|
$179.2B
|
$107.76
|
-5.7%
|
-7.1%
|
-0.8%
|
-0.4%
|
-0.1%
|
-2.3%
|
|
ANET
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$179.2B
|
$107.76
|
-5.7%
|
-7.1%
|
-0.8%
|
-0.4%
|
-0.1%
|
-2.3%
|
|
ANET
|
Technology |
Piper Sandler |
Maintains
|
Neutral
→
Neutral
|
—
|
$179.2B
|
$107.76
|
-5.7%
|
-7.1%
|
-0.8%
|
-0.4%
|
-0.1%
|
-2.3%
|
|
ANET
|
Technology |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$179.2B
|
$107.76
|
-5.7%
|
-7.1%
|
-0.8%
|
-0.4%
|
-0.1%
|
-2.3%
|
|
APP
|
Technology |
Daiwa Capital |
Upgrade
|
Neutral
→
Outperform
|
—
|
$164.9B
|
$246.53
|
+1.0%
|
+17.6%
|
-1.2%
|
+0.9%
|
-1.8%
|
+0.2%
|
|
GILD
|
Healthcare |
Truist |
Maintains
|
Hold
→
Hold
|
—
|
$163.8B
|
$97.90
|
-1.9%
|
-1.4%
|
+0.5%
|
-2.8%
|
-1.8%
|
-0.6%
|
|
GILD
|
Healthcare |
Maxim Group |
Downgrade
|
Buy
→
Hold
|
—
|
$163.8B
|
$97.90
|
-1.9%
|
-1.4%
|
+0.5%
|
-2.8%
|
-1.8%
|
-0.6%
|
|
LOW
|
Consumer Cyclical |
Telsey Advisory GroupD |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$122.3B
|
$266.30
|
+1.0%
|
+1.8%
|
+1.3%
|
-1.7%
|
+0.9%
|
-0.7%
|
|
PGR
|
Financial Services |
TD Cowen |
Maintains
|
Hold
→
Hold
|
—
|
$119.3B
|
$255.27
|
+1.6%
|
+2.4%
|
-0.6%
|
+0.9%
|
-0.4%
|
-1.5%
|
|
FTNT
|
Technology |
Baird |
Maintains
|
Outperform
→
Outperform
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
Scotiabank |
Maintains
|
Sector Outperform
→
Sector Outperform
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
Piper Sandler |
Maintains
|
Neutral
→
Neutral
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
Rosenblatt |
Maintains
|
Buy
→
Buy
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
FTNT
|
Technology |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$95.5B
|
$83.68
|
+1.0%
|
+10.0%
|
+5.6%
|
+2.0%
|
-1.3%
|
-3.5%
|
|
HCA
|
Healthcare |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$93.4B
|
$356.03
|
+0.3%
|
-0.5%
|
+1.1%
|
-2.1%
|
-0.3%
|
-1.1%
|